Skip to content

Korea Equity Lens

  • About
  • IR Room
  • Research
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • EV & Battery
    • Automotive
    • Energy
    • Robotics
    • Shipbuilding
  • Toggle search form
  • [IR] Samsung Electro-Mechanics (009150) – Q3 2024 Earnings Presentation / 2024-10-29 IR Room
  • [Research] Samsung Biologics (207940) – Daishin Securities | Peptide Market Entry · Global Footprint Expansion · Modality Diversification / 2026-07-21 Research
  • [Research] Celltrion (068270/KS) – SK Securities | New Portfolio Mix Expansion · Operating Leverage · H2 Product Launches / 2026-05-07 Research
  • [Research] LIG D&A (079550) – Kiwoom Securities | Defense Export Expansion · GR Turnaround · 2026E Upward / 2026-02-19 Research
  • [IR] SK hynix (000660 / SKHY) – Q3 2024 Earnings Presentation / 2024-10-24 IR Room
  • [Research] Samsung Electro-Mechanics (009150) – Yuanta Securities | MLCC Price Cycle · Customer Prepayments · Server Demand / 2026-08-11 Research
  • [Research] SK hynix (000660 / SKHY) – Mirae Asset | Multi-Year LTA · Price Downside Protection · ROE Sustainability / 2026-04-06 Research
  • [Research] SK hynix (000660 / SKHY) – Kiwoom | Commodity Memory Pricing · Supply Constraints · Earnings Surge / 2026-05-11 Research

[Research] SK hynix (000660 / SKHY) – Hanwha | LTA · Earnings Floor · Cycle Stability / 2026-07-30

Posted on July 30, 2026August 24, 2026 By ksb220805@gmail.com

Market: KOSPI (000660)

Brokerage : Hanwha Investment & Securities

Analyst : Junyoung Park (Nawoo Kim)

Investment Rating : Buy (Maintain)

Target Price : KRW 3,150,000 (Lowered)

Core Momentum : Expanding LTAs are expected to raise the earnings floor through contractual demand and risk-sharing mechanisms, while improving capacity planning and reducing the frequency and severity of memory industry supply-demand cycles.

📊 1. [Valuation & Key Financial Metrics]

  • Stock Performance & Investment Rating
    • Investment Rating: Buy (Maintain)
    • Target Price: KRW 3,150,000 (Lowered, applying 12MF EPS of KRW 432,306 and a 12MF P/E average of 7.3x)
    • Current Price (As of 26/07/29): KRW 1,401,000
    • Upside Potential: 124.8%
  • Valuation Multiples
    • Annual P/E Trend: 2024 51.5x → 2025 23.8x → 2026F 3.7x → 2027F 2.8x
    • Annual P/B Trend: 2024 12.8x → 2025 6.5x → 2026F 2.6x → 2027F 1.4x
    • Annual EV/EBITDA Trend: 2024 26.1x → 2025 16.3x → 2026F 2.9x → 2027F 1.2x
  • Key Financial Forecasts
    • 2024: Revenue KRW 66.19T, Operating Profit KRW 23.47T, Net Profit KRW 19.79T, EPS KRW 27,182, ROE 31.1%
    • 2025: Revenue KRW 97.15T, Operating Profit KRW 47.21T, Net Profit KRW 42.92T, EPS KRW 58,955, ROE 44.2%
    • 2026F: Revenue KRW 335.85T, Operating Profit KRW 262.63T (OPM 78.2%), Net Profit KRW 257.98T, EPS KRW 382,080, ROE 102.9%
    • 2027F: Revenue KRW 496.48T, Operating Profit KRW 415.61T (OPM 83.7%), Net Profit KRW 332.87T, EPS KRW 460,252, ROE 60.9%

🚀 2. [Market Opportunities & Business Outlook]

  • 2Q26 Earnings Review & Stock Correction Diagnosis
    • 2Q26 preliminary results recorded revenue of KRW 79.3T (+51% QoQ, YoY +257%) and operating profit of KRW 60.5T (+60% QoQ, YoY +557%), slightly missing consensus estimates while maintaining solid performance.
    • There are no material changes in explosive earnings or the upcoming 6-quarter trajectory; the recent sharp stock drop is judged to be driven by supply-demand and trading dynamics rather than deteriorating fundamentals.
  • Structural Industrial Changes Driven by LTA Expansion
    • LTAs are not merely extensions of contract durations; they represent risk-sharing structures between suppliers and customers encompassing minimum committed quantities, cost-based pricing, price floors and ceilings, deposits, and supply priority rights.
    • While memory operating margins historically plummeted to 7.0%–10.0% during past down-cycles, expanding LTA proportions (targeting ~50% of total revenue) is projected to lift the operating margin floor to at least 30%.
    • Customer benefits from LTAs include guaranteed supply during shortages and capped prices, maintaining strong retention even in down-cycles due to binding commitments such as deposits and potential loss of priority rights.
  • Expectations for the End of Repetitive Over-Supply Cycles
    • Past vicious cycles in the memory industry stemmed from distorted demand caused by customer double-ordering and subsequent aggressive over-expansion by suppliers.
    • Following LTA expansion, production and capacity planning will rely on concrete contractual demand, significantly mitigating the frequency and intensity of over-supply and lowering structural volatility across the memory industry.

📝 Editor’s Comment (Perspective & Thesis Verification)

The analyst evaluates SK hynix as an enterprise that structurally elevates its earnings floor and reinforces stability through the expansion of long-term agreements (LTAs), despite short-term stock corrections driven by minor consensus misses and supply-demand noise. This perspective places greater emphasis on the structural improvement—namely raising the operating margin floor to at least 30% and reducing industry-wide cyclical volatility via LTAs—rather than short-term market fluctuations.

To verify whether this investment thesis unfolds as expected going forward, it is necessary to track whether SK hynix’s LTA portion actually expands to account for roughly 50% of total revenue, whether the binding nature and earnings-floor defense of LTAs are validated upon entering a down-cycle, and whether double-ordering subsides to alleviate the frequency and intensity of supply gluts. Such changes can be verified through future quarterly and annual earnings releases, official company IR materials, and regulatory filings.

📢 Disclaimer & Source

Source: This content has been structured and newly written based on officially disclosed financial facts and data from brokerage reports.

Investment Risk Notice: This content is provided for informational and linguistic reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific securities. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: Compliance and Copyright Inquiries (ksb220805@gmail.com)

Search by
Company Name or Stock Ticker.
Research, Semiconductors

Post navigation

Previous Post: [Research] SK hynix (000660 / SKHY) – Hana | HBM4 · LTA · Valuation Appeal / 2026-07-30
Next Post: [Research] SK hynix (000660 / SKHY) – Kyobo | HBM4 · Product Mix · LTA / 2026-07-30

Related Posts

  • [Research] Hanwha Ocean (042660) – Yuanta | Merchant Mix Improvement · CPSP Project Value · MASGA Catalysts / 2026-07-06 Shipbuilding
  • [Research] LIG D&A (079550) – Hana Securities | 1Q26 Earnings Beat · Backlog Re-rating · High-margin Follow-on Services / 2026-05-08 Research
  • [Research] Samsung Biologics (207940) – Shinhan Securities | Capacity Expansion · Peptide Entry · Guidance Upgrade / 2026-07-24 Research
  • [Research] Samsung Biologics (207940) – Shinhan Securities | Rockville Revenue Recognition · Guidance Revision Potential · Songdo Plant 6 Groundbreaking / 2026-04-23 Research
  • [Research] Samsung SDI (006400) – iM Securities | AIDC ESS Demand · US Regulation Benefits · Profit Turnaround / 2026-06-30 Research
  • [Research] SK hynix (000660 / SKHY) – iM Securities | Fixed Memory Pricing · Supply Shortage · Earnings Growth / 2026-01-30 Research
  • [Research] Samsung Electro-Mechanics (009150) – Hana Securities | AI MLCC Shortage · FCBGA Pricing Power · Valuation Premium / 2026-07-01 Research
  • [Research] SK hynix (000660 / SKHY) – SK Securities | LTA · Earnings Visibility · Shareholder Returns / 2026-08-03 Research
  • [Research] SK hynix (000660 / SKHY) – Hanwha | LTA · HBM · Earnings Sustainability / 2026-04-24 Research
  • [Research] Samsung Biologics (207940) – Mirae Asset | Plant 5 Ramp-up · CDMO Expansion · Earnings Forecast / 2026-07-27 Research
  • [Research] Celltrion (068270/KS) – SK Securities | New Portfolio Mix Expansion · Operating Leverage · H2 Product Launches / 2026-05-07 Research
  • [Research] LIG D&A (079550) – Daishin Securities | 1Q26 Review · Earnings Surprise · Export Diversification / 2026-05-08 Research
  • [Research] Alteogen (196170) – Daishin Securities | Validated ALT-B4 Platform · Keytruda SC Milestones Accelerate · Coverage Initiation / 2026-05-19 Research
  • [Research] Samsung Electro-Mechanics (009150) – Yuanta Securities | MLCC Price Hikes · Server Product Mix · Target Price Revision / 2026-07-31 Research

Copyright © 2026 Korea Equity Lens.

Powered by PressBook News Dark theme